Catalogo dei prodotti della ricerca

RUGHETTI, Aurelia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.667
EU - Europa 1.895
AS - Asia 920
AF - Africa 71
SA - Sud America 46
OC - Oceania 5
Totale 6.604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.628
IT - Italia 1.026
SG - Singapore 348
SE - Svezia 276
IN - India 253
CN - Cina 202
UA - Ucraina 159
FI - Finlandia 148
DE - Germania 85
GB - Regno Unito 52
AR - Argentina 41
ID - Indonesia 34
CA - Canada 33
EG - Egitto 32
HK - Hong Kong 28
BG - Bulgaria 27
IE - Irlanda 26
TG - Togo 25
FR - Francia 23
KR - Corea 19
CH - Svizzera 17
IR - Iran 14
BE - Belgio 9
NL - Olanda 9
ZA - Sudafrica 9
RO - Romania 8
PL - Polonia 7
JP - Giappone 6
AU - Australia 5
MX - Messico 5
RU - Federazione Russa 5
DK - Danimarca 4
ES - Italia 4
TW - Taiwan 4
AT - Austria 3
CI - Costa d'Avorio 3
CO - Colombia 3
BR - Brasile 2
GR - Grecia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MA - Marocco 2
MK - Macedonia 2
NO - Norvegia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CU - Cuba 1
KH - Cambogia 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
TH - Thailandia 1
TR - Turchia 1
Totale 6.604
Salva come PNG Salva come JPEG
Città #
Rome 522
Fairfield 511
Chandler 315
Ashburn 250
Woodbridge 250
Singapore 226
Seattle 202
Cambridge 180
Houston 178
Wilmington 161
Ann Arbor 150
New York 118
Princeton 106
Plano 82
Beijing 77
Santa Clara 64
Helsinki 62
San Paolo di Civitate 62
Jacksonville 61
Milan 53
Boston 52
Lawrence 52
Millbury 39
San Diego 35
Boardman 34
Jakarta 34
Dearborn 32
Damanhur 29
Federal 29
Sofia 27
Andover 26
Dublin 26
Lomé 25
Hong Kong 23
Des Moines 21
Hyderabad 20
Norwalk 18
Falls Church 17
Perugia 17
Toronto 16
Fremont 15
York 15
Bremen 13
Los Angeles 13
Lappeenranta 12
Indore 11
Shanghai 11
Salt Lake City 10
Turin 10
Albano Laziale 9
Brussels 9
Dallas 9
Munich 8
Phoenix 8
London 7
Naples 7
Palermo 7
Falkenstein 6
Hefei 6
Leawood 6
Montreal 6
Putignano 6
Bari 5
Casatenovo 5
Chicago 5
Diano d'Alba 5
Florence 5
Grafing 5
Guangzhou 5
Hangzhou 5
Kunming 5
Modena 5
Pomezia 5
Redwood City 5
San Isidro 5
San Mateo 5
Wuhan 5
Bühl 4
Ercolano 4
Frankfurt am Main 4
Fuzhou 4
Goyang-si 4
Livorno 4
Mexico City 4
Muizenberg 4
Ottawa 4
Philadelphia 4
Pune 4
Reggio Calabria 4
Renens 4
Seoul 4
Stockholm 4
Trento 4
Zanjan 4
Aachen 3
Abidjan 3
Amsterdam 3
Auburn Hills 3
Avellino 3
Bengaluru 3
Totale 4.567
Salva come PNG Salva come JPEG
Nome #
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients 154
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway 152
The macrophage Galactose-type C-type Lectin (MGL) modulates regulatory T cell functions 138
Bevacizumab-based chemotherapy triggers immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector t cell subsets 132
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial 117
Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response 106
Anisakis pegreffii impacts differentiation and function of human dendritic cells 106
Tumor Associated Tn-MUC1 Glycoform is Internalized through the Macrophage Galactose-type C-type Lectin and delivered to the HLA Class I and II Compartments in Dendritic Cells. 98
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response 98
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma 98
MGL receptor and immunity: when the ligand can make the difference 96
Tumor-derived microvesicles modulate antigen cross-processing via reactive oxygen species-mediated alkalinization of phagosomal compartment in dendritic cells 92
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer. A meta-analysis 90
Immune effects of trastuzumab. 86
Immunological and clinical impact of cancer stem cells in vulvar cancer: role of CD133/CD24/ABCG2-Expressing Cells 86
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells 85
Past, present and future strategies of immunotherapy in gynecological malignancies 84
Cancer testis antigen expression in primary and recurrent vulvar cancer: Association with prognostic factors 83
null 83
The epithelial mucin MUC1 contains at least two discrete signals specifying membrane localization in cells 81
Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing. 81
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines 79
Anticorpi monoclonali contro la lipasi da Candida rugosa 78
Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region 78
Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer 77
Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression 77
Gene expression profiles of antigenic proteins of third stage larvae of the zoonotic nematode Anisakis pegreffii in response to temperature conditions 76
Multicentre harmonisation of a six-colour flow cytometry panel for naïve/memory T cell immunomonitoring 76
Multiple Tumor Associated Peptide Vaccination As Consolidation Treatment In Women Affected by Breast and Ovarian Cancer 75
Characterization of monoclonal antibody 436 recognizing the ARG-PRO-ALA-PRO sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma cells 73
Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. 73
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach 72
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study 72
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma 71
Human decay accelerating factor transgenic pigs for xenotransplantation obtained by sperm-mediated gene transfer 71
A comparative analysis of serum and serum-free media for generation of clinical grade DCs 70
Funzione immunoregolatoria dell'antigene tumore associato MUC1 durante l'ematopoiesi 69
The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSF. 67
Distinct pathways of antigen processing of MUC1 tumor-associated glycoprotein in dendritic cells (DCs) 65
Clinical and Developmental Immunology 65
Recombinant tumor associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. 64
null 64
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients 63
bcl-2 overexpression inhibites apoptosis and promotes the phenotype and morphological differentiation of human mammary epithelial cells 63
MGL lectin receptor and immunosuppression networks in glioblastoma 62
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line 62
RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients 61
null 60
Regulated expression of MUC1 epithelial antigen in erythropoiesis 60
Monoclonal antibodies in gynecological cancer: a critical point of view. 59
Circulating CD137+T cells as an immune biomarker for response to anti-PD1 immunotherapy in NSCLC patients 58
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - Proceedings from the SOGLI consortium meeting in rome November 2022 58
Effects of G-CSF and GM-CSF administration on T cell proliferation and phagocyte cell surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation 57
Immune response to the polymorphic epithelial mucin (PEM) 56
Monoclonal antibodies against Candida rugosa lipase 56
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells 54
Immunohistochemical analysis of the distribution of a breast tumor associated antigen recognized by a monoclonal antibody 54
Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice 53
T cell activation induced by MUC1 synthetic glycopeptides 51
Investigating patterns of immune interaction in ovarian cancer: probing the O-glycoproteome by the macrophage galactose-like C-type Lectin (MGL) 51
Macrophage galactose-like lectin mediated interactions: investigating immunosuppressive mechanisms in glioblastoma 49
Antimicrobial lipase antibody their nucleotide and aminoacid sequences and uses thereof 49
Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation 49
Combining anti-tumor immunotherapy and tumor ablation techiniques: immunological and biological basis. 47
HER2-based recombinant immunogen to target DCs through Fc gamma Rs for cancer immunotherapy 47
Enhancement of Candida rugosa lipase activity by immunoglobulin light chain 47
Seasonal modulation of the C-type lectin MGL on human DCs 47
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells 47
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma 46
ANTIMICROBIAL LIPASE ANTIBODIES THEIR NUCLEOTIDE AND AMINOACID SEQUENCES AND USES THEREOF”. 45
Transfected human dendritic cells to induce antitumor immunity 45
null 45
Immunoglobulin light chain increases enzymatic activity of Candida rugosa lipase. 43
Generation and characterisation of monoclonal antibodies against lipases from Candida rugosa 43
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients 42
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance 41
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors 41
Human B-cell immune response to the polymorphic epithelial mucin. 41
MUC1 expression in non lymphoid differential cell lineages from CD34+ cells 40
Engagement of MGL by the Tn-tumor glycoform of MUC1 induces DC signaling and activation 40
hDAF TRANSGENIC PIG GENERATION: A NEW SOURCE OF ORGANS FOR XENOTRANSPLANTATION 40
Polymeric nanoparticles decorated with monoclonal antibodies: a new immobilization strategy for increasing lipase activity 40
Breaking tolerance against MUC1 self antigen: implication for immunotherapy 39
DCs internalize and efficiently process Tn-MUC1 glycoprotein through MGL. 39
Isolation of MUC-1 primed B lymphocytes from tumour draining lymph nodes using immunomagnetic beads. 39
Enhancement of Candida rugosa lipase activity by immunoglobulin light chain 39
Exosomes factory: a new strategy for antitumour vaccines 39
Exosome factory: a new strategy for antitumor vaccines. 38
In normal aging ventricular system never attains pathological values of Evans' index 37
Proteomic characterization of extracellular vesicles released by third stage larvae of the zoonotic parasite anisakis pegreffii (Nematoda: Anisakidae) 36
Treg/CD137+ T cell balance as a novel biomarker of survival in advanced non-addicted NSCLC patients treated with immunotherapy as first-line 36
MAGE-A and NY-ESO-1 expression in cervical cancer: investigation on prognostic factors and effect of chemotherapy 35
MUC1 cross talk molecule during erythroid differentiation. 34
Network analysis to unveil lectins-mediated immunosuppression in glioblastoma 33
Circulating immunosuppression correlates with worse clinical outcome in head and neck cancer patients undergoing immunotherapy treatment 33
Immunomodulatory effects of radiofrequency tumor ablation in liver tumor patients. 33
Dendritic cells for MUC1-based cancer immunotherapy 33
Exosome factory: new strategy for the production of cell-free antitumor vaccines 33
Immunogenic cell death and immunomodulatory effects of cabozantinib 33
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients 32
Totale 6.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 330
selected - selezionate 0
volume - volumi 0
Totale 23.095
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020813 0 0 0 0 102 124 139 126 101 126 64 31
2020/2021539 52 49 34 44 44 40 12 42 50 113 45 14
2021/20221.164 30 58 86 41 144 32 31 100 92 85 264 201
2022/20231.323 234 245 79 129 136 139 28 100 85 35 55 58
2023/20241.146 48 120 54 71 128 252 45 102 16 125 94 91
2024/2025817 169 123 183 168 174 0 0 0 0 0 0 0
Totale 6.940